Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2015
A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation StatusFloriane Fusil, Sara Calattini, Fouzia Amirache, et al.
Hepatology (Baltimore, Md.)|December 15, 2018
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human HepatocytesCarmen Unzu, Evarist Planet, Nathalie Brandenberg, et al.
Blood Advances|November 20, 2020
Combining T-cell-specific activation and in vivo gene delivery through CD3-targeted lentiviral vectorsAnnika M Frank, Angela H Braun, Lea Scheib, et al.
Carcinogenesis|October 2, 2015
The mycotoxin aflatoxin B1 stimulates Epstein-Barr virus-induced B-cell transformation in in vitro and in vivo experimental modelsRosita Accardi, Henri Gruffat, Cécilia Sirand, et al.
The Journal of Biological Chemistry|July 31, 2015
Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse ModelSara Calattini, Floriane Fusil, Jimmy Mancip, et al.
Retrovirology|November 13, 2014
ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activityAnne Cachat, Sandrine Alais, Sébastien Alain Chevalier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2011
Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat β-thalassemiaKeshet Ronen, Olivier Negre, Shannah Roth, et al.
Antiviral Research|July 16, 2017
Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vectorJulie Lucifora, Anna Salvetti, Xavier Marniquet, et al.
Scientific Reports|March 31, 2018
Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytesJulie Lucifora, Marc Bonnin, Ludovic Aillot, et al.
Antiviral Research|May 15, 2026
A subset of Histamine H4 receptor antagonists prevents B lymphocyte proliferation induced by BCR/TLR9 engagement or EBV infectionMarlène Roy, Emilie Bardel, Laura Gromolard, et al.
Pageof 4